About Jeffrey Barnes, MD, PhD

Jeffrey Barnes, MD, PhD is a graduate of the University of Illnois College of Medicine. He completed his residency in Internal Medicine at the Beth Israel Deaconess Medical Center in Boston. He then completed his fellowship in Medical Oncology at the Dana Farber Cancer Institute before joining the faculty at the Massachusetts General Hospital. He is a member of the US Cutaneous Lymphoma Consortium. His research interests focus on the identification and evaluation of novel agents for the treatment of lymphoma.

Clinical Interests:

Treats:

Locations

Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Fax: 617-726-8330

Martha's Vineyard Hospital
1 Hospital Rd.
Oak Bluffs, MA 02557
Phone: 508-693-0410

Mass General Cancer Center at Newton-Wellesley
2014 Washington St.
Newton, MA 02462
Phone: 617-219-1230

Medical Education

  • , University of Illinois College of Medicine at Urbana-Champaign
  • Fellowship, Dana Farber Cancer Institute

American Board Certifications

  • Hematology, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Barnes performs translational research in lymphoma including clinical trials of novel therapies for the treatment of cutaneous lymphoma, non-Hodgkin lymphomas, Hodgkin lymphoma (Hodgkin's disease), and chronic lymphocytic leukemia.

Publications

  • Select Publications:

    • Barnes JA, Abramson JS. Differential Diagnosis and Novel Treatment Strategies for Adult T Cell Leukemia Lymphoma. Oncology. Dec 23;14, p.1267-1270 (2009)
    • Abramson JS, Hellmann M, Barnes JA, Hammermann P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP. Intravenous methotrexate as central nervous system prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer Jun 8 Epub ahead of print (2010)
    • Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuburg D, Tomey C, Hochberg EP, Canellos GP, Abramson JS. End of treatment but not interim PET scan predicts outcomes in non-bulky limited stage Hodgkin lymphoma. Ann of Oncology  Oct 15 (2010)
    • Barnes JA, LaCasce AS, Feng Y, Tomey C, Neuburg D, Michaelson JS, Hochberg EP, Abramson JS. Evaluation of the Addition of Rituximab to CODOX-M/IVAC for Burkitt Lymphoma: A Retrospective Analysis. Ann of Oncology In Feb 21 (2011)

Reviews: Comments and Ratings

4.9out of 5(376 Ratings, 147 Comments)

January 2025

Dr. Barnes is the absolute best, and his staff is the same.


January 2025

he was gentle and careful with the procedures, pleasant and considerate.


January 2025

Dr Barnes first put me at ease about a leukemia diagnosis based on a blood test. He very carefully explained my diagnosis and using his scientific knowledge explained in Layman's terms that i did not have a significant risk of serious further cancer risk and if I did there were several proven treatment options. I was impressed by his level of ... Read More


January 2025

Dr. Barnes is an excellent physician. He listens carefully and always responds in a positive manner. He is very interested in my well being.


January 2025

Yes, Dr. Barnes is an excellent oncologist. I've been with him for about 10 years and he's taken care of me very well. That's all I got.


January 2025

Dr. Barnes is amazing! He's done the most thorough review of all my history, going back at least 15 years to diagnose my complicated and somewhat uncommon conditions, and has followed up meticulously. I am incredibly grateful for his wonderful care and support!


January 2025

Dr. Barnes and the entire staff at the Infusion center are the BEST


January 2025

Dr. Barnes is a wonderful and always attentive physician.


January 2025

Very helpful


December 2024

It was my first visit with Dr. Barnes. He explained well what was going on with my cancer, reviewed my test results with me and told what I could expect. He was personable and caring.

View More
Ratings and Comments Powered by NRC Health